Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Peptic Ulcer Testing
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$410.6 Million by ... Read More
-
Infection Surveillance Solutions
... by 2030, growing at a CAGR of 14.2% over the period 2023-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record 13.7% CAGR and reach US$1.2 Billion by the ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
-
Pediatric Drugs and Vaccines
... reach US$156.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Conjugate Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... reach US$49.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% ... Read More
-
Lymphoma Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More
-
Endometriosis Drugs
... at a CAGR of 3.0% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Tinea Pedis (Athlete`s Foot) Treatment
... is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 3.3% ... Read More
-
Adult Stores
... at a CAGR of 6.8% over the analysis period 2023-2030. Sex Toys, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$34.6 Billion by the end of ... Read More
-
Prescription Drugs
... at a CAGR of 5.7% over the analysis period 2023-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$498.0 Billion by the end of the ... Read More
-
Oncology Nutrition
... at a CAGR of 9.4% over the analysis period 2023-2030. Head & Neck Cancer Nutrition, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$609.6 Million by ... Read More
-
Global Age-Related Macular Degeneration Market Forecast Report by Disease Type (Dry Age-Related Macular Degeneration Market, Wet Age-Related Macular Degeneration Market) Product (Eylea, Lucentis, Beovu, Others) Distribution Channel (Hospital Pharmacy, Specialty Pharma, Online Pharmacy) Countries and Company Analysis, 2024-2032
... Company Analysis, 2024-2032 Age-Related Macular Degeneration Market Analysis The Global Age-Related Macular Degeneration market is forecasted to reach US$ 19.53 billion by 2032 from US$ 10.68 billion in 2023, and compound annual growth rate of ... Read More
-
2024 France Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
... evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors ... Read More
-
Nicotine Gum Market Report by Type (2 Mg Nicotine Gum, 4 Mg Nicotine Gum, 6 Mg Nicotine Gum), Application (Withdrawal Clinics, Medical Practice, Individual Smokers, and Others), Distribution Channel (Retail Pharmacies, Specialty Stores, Online Stores, and Others), and Region 2024-2032
... and Others), and Region 2024-2032 The global nicotine gum market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate ... Read More
-
Orthopedic Veterinary Implants
... by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Veterinary Bone Plates, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$86.4 Million ... Read More
-
Asia Pacific Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032
... chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032 Asia Pacific Esoteric Testing Market is valued approximately at USD 3.53 Billion in 2023 and is ... Read More
-
Renal Denervation Technologies
... by 2030, growing at a CAGR of 41.7% over the analysis period 2023-2030. Radiofrequency Based Renal Denervation Technologies, one of the segments analyzed in the report, is expected to record a 41.2% CAGR and reach ... Read More
-
Cancer Therapies
... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More
-
Carotid Stents
... at a CAGR of 8.7% over the analysis period 2023-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$4.3 Billion by the end ... Read More
-
Antibiotics
... of 3.1% over the analysis period 2023-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth ... Read More
-
Brachytherapy
... of 4.4% over the analysis period 2023-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Human Growth Hormone Drugs
... reach US$5.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach ... Read More
Research Assistance
